Investor relations
Soundly financed, run by entrepreneurs
medudoc is backed by shareholders who run the company themselves or support it closely. This gives us the freedom to develop the platform over the long term.
Our story
From an idea to a platform for the preoperative workflow
medudoc was founded in 2020 with the aim of fundamentally changing patient education. Today's management came on board as an investor in 2022 and has supported this path ever since.
In November 2025, today's management, together with other investors, took over the majority of medudoc and contributed additional capital. This marks the start of a new phase – from a provider of patient education videos to a platform for the entire preoperative workflow.
2020
Founding of medudoc gmbh
2022
Today's management invests in the company
2025
Majority takeover by today's management, additional capital and an expanded management team
2026
ISO/IEC 27001:2022 certification and expansion of the platform in Germany, Austria and Switzerland
Ownership structure
Who is behind medudoc
Four core shareholders together hold a clear majority in medudoc gmbh. The remaining shares are held by other shareholders.
72%
Core shareholders72%
Other shareholders28%
make visions group
make visions group is an early-stage investor that supports companies on their path to scale. With its finance and legal departments, it provides the resources needed for secure growth.
make-visions.comFinancing
A partner that plans for the long term
With the majority takeover, our shareholders contributed additional capital. medudoc is therefore soundly financed and can take the next steps under its own steam. For hospitals, this means a partner that invests in the platform and will still be there in the future.
Where the capital goes
- Product development and platform architecture
- Regulatory scalability and information security
- Expansion in Germany, Austria and Switzerland
- Market entry beyond the DACH region
Investor contact
In dialogue with investors and partners
We welcome conversations with investors and strategic partners who share our conviction. Your contact is Martin Klässner.
Martin Klässner